-transparent.png){kind=logo}
Clinical, biochemical and nerve conduction studies were performed in 100 cases of tuberculosis taking isonicotinic acid hydrozide (isoniazid) for more than 12 weeks. Electro-physiological studies were carried out in a similar number of normal age and sex matched controls. In 16 percent of cases an abnormality was documented in the motor nerve conduction velocity, amplitude and terminal latency of the common peroneal, ulnar and median nerves; of these, only two patients had objective evidence of neuritis. The occurrence of isoniazid neuropathy was found to be more in the fourth decade of life (10 of 16), in those who had taken the drug for over six months (13 of 16), and in 'slow' inactivators (10 of 16).
U C Goel, and
S Bajaj, and
O P Gupta, and
N C Dwivedi, and
A L Dubey
May 1990,
British journal of clinical pharmacology,
U C Goel, and
S Bajaj, and
O P Gupta, and
N C Dwivedi, and
A L Dubey
February 1978,
Clinical pharmacology and therapeutics,
U C Goel, and
S Bajaj, and
O P Gupta, and
N C Dwivedi, and
A L Dubey
January 1997,
British journal of clinical pharmacology,
U C Goel, and
S Bajaj, and
O P Gupta, and
N C Dwivedi, and
A L Dubey
September 1978,
The American review of respiratory disease,
U C Goel, and
S Bajaj, and
O P Gupta, and
N C Dwivedi, and
A L Dubey
March 1976,
Annals of tropical medicine and parasitology,
U C Goel, and
S Bajaj, and
O P Gupta, and
N C Dwivedi, and
A L Dubey
January 2002,
Acta poloniae pharmaceutica,
U C Goel, and
S Bajaj, and
O P Gupta, and
N C Dwivedi, and
A L Dubey
January 2002,
Pneumonologia i alergologia polska,
U C Goel, and
S Bajaj, and
O P Gupta, and
N C Dwivedi, and
A L Dubey
July 1992,
Journal of the neurological sciences,
U C Goel, and
S Bajaj, and
O P Gupta, and
N C Dwivedi, and
A L Dubey
January 1984,
European journal of clinical pharmacology,
U C Goel, and
S Bajaj, and
O P Gupta, and
N C Dwivedi, and
A L Dubey
January 1987,
European journal of clinical pharmacology,
